Core Viewpoint - The stock of Maide Medical (688310) has shown a slight increase, with a closing price of 16.13 yuan on January 9, 2026, reflecting a 1.13% rise, amidst varied capital flows [1]. Group 1: Stock Performance - As of January 9, 2026, Maide Medical's stock closed at 16.13 yuan, up by 1.13% with a turnover rate of 1.6% and a trading volume of 26,600 hands, resulting in a transaction amount of 42.53 million yuan [1]. - The net outflow of main funds was 6.24 million yuan, accounting for 14.66% of the total transaction amount, while retail investors saw a net inflow of 3.84 million yuan, representing 9.02% of the total [1]. Group 2: Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.84 million yuan, up by 15.82% [2]. - In Q3 2025, the company achieved a single-quarter main revenue of 83.64 million yuan, reflecting a significant year-on-year increase of 54.38%, and a net profit of 2.79 million yuan, which is a 224.07% increase compared to the same quarter last year [2]. - The company reported a debt ratio of 29.86%, with an investment income of 0.17 million yuan and financial expenses of -0.52 million yuan, alongside a gross profit margin of 40.19% [2]. Group 3: Business Overview - Maide Medical specializes in the research, development, production, sales, and service of medical consumables and intelligent equipment, integrating technology in medical device processes, automation, and software to create unique product and service advantages [2].
股票行情快报:迈得医疗(688310)1月9日主力资金净卖出623.67万元